Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 13, 2022

SELL
$2.8 - $7.39 $24,242 - $63,982
-8,658 Closed
0 $0
Q4 2021

Mar 14, 2022

BUY
$5.92 - $9.98 $51,255 - $86,406
8,658 New
8,658 $59,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Exos Asset Management LLC Portfolio

Follow Exos Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exos Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exos Asset Management LLC with notifications on news.